NB-001 in Children and Adolescents With 22q11 Deletion Syndrome

NCT05290493 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

22q11 Deletion Syndrome

Interventions

DRUG: NB-001
OTHER: Placebo

Sponsor

Nobias Therapeutics, Inc.